|
|
||||||||
Letters to the Editor |
a Lung Cancer Unit, National Cancer Research Institute, Genoa, Italy
b Thoracic Surgery Unit, Catholic University, Rome, Italy
c Pulmonary Rehabilitation, IRCCS San Raffaele, Rome, Italy
Received 5 September 2007; accepted 21 September 2007.
* Corresponding author. Address: General Thoracic Surgery, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy. Tel.: +39 06 30156326; fax: +39 03 3051162. (Email: alfcesario@yahoo.com).
Key Words: Inflammation COPD Apoptosis C-reactive protein Lung cancer
| The first 20% of the full text of this article appears below. |
We appreciated the reading of the work of Amar et al. [1]. The authors reported data suggesting that markers of inflammation such as C-reactive protein (CRP) and IL-6 can help to classify patients who are at high risk for major postoperative complications (PC) following thoracic surgery. Systemic inflammation is thus considered to be important in the pathogenesis of important PC. Defining the precise inflammatory response represents a sensitive issue, frequently debated within scientific community. Plasma levels of cytokines or CRP are probably not sufficient to determine whether a patient or experimental animal is hyper-inflammatory or hypo-inflammatory. If only the
This article has been cited by other articles:
![]() |
D. Amar, B. Park, and P. M. Heerdt Reply to Paleari et al. Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 950 - 951. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |